SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-007796
Filing Date
2017-08-02
Accepted
2017-08-01 18:15:25
Documents
54
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20170630-10q.htm 10-Q 947117
2 EXHIBIT 10.1 ex-101xdeegmarkemploymenta.htm EX-10.1 103765
3 EXHIBIT 10.2 ex-102xhaganjaybasesalarya.htm EX-10.2 1756
4 EXHIBIT 10.3 ex-103xgrintpaulseparation.htm EX-10.3 111187
5 EXHIBIT 31.1 ex-311x20170630.htm EX-31.1 12043
6 EXHIBIT 31.2 ex-312x20170630.htm EX-31.2 12071
7 EXHIBIT 32.1 ex-321x20170630.htm EX-32.1 11538
14 paulgrintseparationag_image1.gif GRAPHIC 51059
  Complete submission text file 0001628280-17-007796.txt   4517965

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rgls-20170630.xml EX-101.INS 842977
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20170630.xsd EX-101.SCH 31325
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20170630_cal.xml EX-101.CAL 51588
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20170630_def.xml EX-101.DEF 144915
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20170630_lab.xml EX-101.LAB 432661
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20170630_pre.xml EX-101.PRE 240663
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 17997853
SIC: 2834 Pharmaceutical Preparations